7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

Care of the cardiac surgical patient beyond the initial 48-hour intensive resuscitation phase transitions focus toward preventing, identifying, and managing subacute and late postoperative complications. Critical care and step-down nurses must master the management of Post-Pericardiotomy Syndrome, late-onset atrial fibrillation, deep sternal wound infections (mediastinitis), bypass graft failure mechanisms, and secondary prevention targets mandated by the AACN Synergy Model.

---

Subacute Postoperative Transition (>48 Hours Post-Op)

As patients transition from the ICU to telemetry/step-down units, Invasive lines, epicardial pacing wires, and chest tubes are systematically evaluated for removal.

Removal Criteria & Clinical Safeguards

• Chest Tubes: Removed when 24-hour drainage is < 100 - 150 mL of clear serous fluid, without active bleeding, and with complete resolution of pleural air leaks. Post-removal monitoring: Obtain chest radiograph 2–4 hours post-pull to rule out pneumothorax or hemothorax.
• Epicardial Pacing Wires: Removed prior to discharge when underlying sinus node and AV nodal conduction are stable. Safety Precaution: Pacing wire removal carries a small risk of atrial or ventricular laceration, myocardial bleeding, and acute cardiac tamponade. Monitor vital signs q15min for 1 hour post-pull and watch for signs of Beck's triad.
• Pharmacological Transition: Wean continuous vasoactive infusions; optimize oral guideline-directed medical therapy (GDMT) including Beta-Blockers, ACE inhibitors / ARBs, Statins, and Antiplatelet agents.

---

Post-Pericardiotomy Syndrome (PPS)

Post-Pericardiotomy Syndrome is an immune-mediated inflammatory response involving the pericardium and pleura, triggered by surgical trauma, cardiac incision, and residual micro-hemorrhage within the pericardial cavity.

Epidemiology & Clinical Presentation

• Onset: Typically occurs 1 to 6 weeks postoperatively (incidence 10%–40%).
• Diagnostic Criteria (Requires at least 2 of the following 5 criteria):
  1. Fever without an infectious source.
  2. Pleuritic chest pain (sharp, radiating to trapezius ridge, worsened by deep inspiration or lying flat, improved by sitting upright and leaning forward).
  3. Pericardial friction rub (scratchy, triphasic murmur heard best at left lower sternal border during end-expiration with patient leaning forward).
  4. New or worsening pericardial effusion (echocardiogram) or pleural effusion (chest X-ray).
  5. Elevated inflammatory markers: C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR).
• ECG Findings: Diffuse concavity-upward (saddle-back) ST-segment elevations across multiple leads with PR-segment depression (except lead aVR, which shows ST depression and PR elevation).

Pharmacological Management

---

Late Postoperative Atrial Fibrillation (POAF)

Postoperative Atrial Fibrillation is the most common arrhythmia following cardiac surgery, occurring in 30% to 50% of patients, with a peak incidence on postoperative days 2 to 4.

Risk Factors & Pathophysiology

Driven by surgical atrial trauma, postoperative systemic inflammation, pericarditis, elevated atrial filling pressures, withdrawal of pre-op beta-blockers, and heightened sympathetic tone.

Management Strategy

1. Prophylaxis: Continuation or early re-institution of oral Beta-Blockers postoperatively is the single most effective intervention to prevent POAF.
2. Rate Control: Target resting Heart Rate < 110 bpm using IV or oral Beta-Blockers (Metoprolol) or Non-dihydropyridine Calcium Channel Blockers (Diltiazem). In patients with severe LV dysfunction or hypotension, Digoxin or Amiodarone is preferred.
3. Rhythm Control: Amiodarone (IV loading infusion 150 mg over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours, transitioning to oral taper) is the drug of choice for symptomatic or refractory POAF. Synchronized Direct Current Cardioversion (DCCV) is indicated for hemodynamic instability.
4. Anticoagulation Mandate: If POAF persists for > 48 hours or recurs, therapeutic anticoagulation (DOACs such as Apixaban, Rivaroxaban, or Warfarin) must be initiated and maintained for at least 60 days, guided by CHA₂DS₂-VASc stroke risk scoring and post-op bleeding assessment.

---

Sternal Wound Care & Deep Sternal Wound Infection (DSWI) / Mediastinitis

Sternal wound complications range from superficial incisional infections to catastrophic Deep Sternal Wound Infection (DSWI) and acute mediastinitis.

Sternal Precautions (6 to 8 Weeks Post-Op)

To ensure sternal bony healing and prevent dehiscence:

• No lifting, pushing, or pulling > 5 - 10 lbs.
• Avoid using arms to push up from a chair (use leg muscles).
• Hug a sternal pillow / harness tightly against the chest during coughing, sneezing, or movement transitions.
• Avoid bilateral overhead arm extension or excessive trunk twisting.

Deep Sternal Wound Infection (DSWI) & Mediastinitis

• Incidence & Risk Factors: Occurs in 1%–2% of cardiac surgeries, carrying a mortality rate up to 40%. Risk factors include obesity, diabetes mellitus (poor perioperative glycemic control > 180 mg/dL), bilateral internal mammary artery (BIMA) harvesting (devascularizes sternum), prolonged mechanical ventilation, and re-exploration for bleeding.
• Clinical Presentation: Sternal instability ("clicking," movement, or separation on palpation), severe localized sternal pain, purulent wound drainage, high fever, leukocytosis, and systemic sepsis.
• Causative Microorganisms: Staphylococcus aureus (including MRSA), Staphylococcus epidermidis (Coagulase-negative Staph), and Gram-negative bacilli.
• Emergency Interventions:
  1. Immediate Surgical Debridement: Emergent re-exploration in the OR with radical excision of infected bone, cartilage, and soft tissue.
  2. Broad-Spectrum IV Antibiotics: Immediate empiric therapy with IV Vancomycin + Cefepime (or Meropenem), tailored to wound cultures.
  3. Negative Pressure Wound Therapy (NPWT / VAC): Placed to sub-atmospherically drain mediastinal wound bed.
  4. Delayed Reconstruction: Soft tissue closure utilizing Pectoralis major or Rectus abdominis muscle flaps.

---

Bypass Graft Failure & Occlusion Mechanisms

Understanding coronary artery bypass graft (CABG) anatomy and patency dynamics is crucial for evaluating recurrent post-op ischemia.

                         CORONARY ARTERY BYPASS GRAFTS
                                       │
                ┌──────────────────────┴──────────────────────┐
                ▼                                             ▼
     INTERNAL MAMMARY ARTERY                      SAPHENOUS VEIN GRAFT
         (LIMA / RIMA)                                   (SVG)
                │                                             │
  • In-situ arterial conduit                   • Harvested saphenous vein
  • Pedicled graft to LAD                      • Aortic-to-coronary interposition
  • 10-Year Patency: >90-95%                   • 10-Year Patency: ~50%
  • Resistant to atherosclerosis               • High rate of intimal hyperplasia
  • Endothelial Nitric Oxide release             & late atheroma failure

Mechanisms of Graft Failure

1. Early SVG Failure (<1 Month): Thrombotic occlusion caused by surgical endothelial trauma, graft kinking, small target vessel diameter, or low blood flow. Prevention: Aspirin 81–325 mg PO daily initiated within 6 hours postoperatively.
2. Late SVG Failure (>1 Year): Progressive smooth muscle cell proliferation (intimal hyperplasia) followed by friable, diffuse concentric atherosclerosis. Prevention: High-intensity statins (Atorvastatin 80 mg) to slow SVG atheroma growth.
3. LIMA Superiority: The Left Internal Mammary Artery (LIMA) grafted to the Left Anterior Descending (LAD) artery is the gold standard conduit, maintaining > 90% patency at 10 years due to its intact internal elastic lamina and continuous endothelial nitric oxide production.

---

Phase II Cardiac Rehabilitation & AACN Synergy Model

Long-term recovery and secondary prevention rely on structured outpatient Phase II Cardiac Rehabilitation (36 sessions initiating 2–4 weeks post-discharge) and application of the AACN Synergy Model for Patient Care.

AACN Synergy Model Competency Integration

• Clinical Judgment: Recognizing subtle signs of late graft failure or deep mediastinitis before hemodynamic collapse occurs.
• Advocacy & Moral Agency: Ensuring vulnerable post-op patients receive appropriate cardiac rehab referrals and access to essential secondary prevention medications.
• Caring Practices: Providing comprehensive education on sternal precautions, wound care, and anxiety management during the transition to home.